LENZ Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $5,000 | $0 | $66 | $0 |
Gross Profit | 5,000 | -36 | 33 | -10 |
EBITDA | -16,838 | -16,895 | -15,200 | -12,935 |
EBIT | -16,857 | -16,931 | -15,225 | -12,945 |
Net Income | -14,912 | -14,619 | -12,652 | -10,215 |
Net Change In Cash | 5,000 | 0 | 66 | 0 |
Free Cash Flow | -11,748 | -16,159 | -9,227 | -10,767 |
Cash | 37,608 | 23,042 | 20,158 | 41,046 |
Basic Shares | 28,079 | 27,526 | 27,492 | 27,172 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $15,000 | $0 |
Gross Profit | -58 | -2,407 | 6,654 | -734 |
EBITDA | -49,710 | -122,244 | -97,293 | -70,026 |
EBIT | -49,768 | -122,259 | -105,639 | -70,760 |
Net Income | -49,769 | -124,651 | -101,052 | -70,760 |
Net Change In Cash | 0 | 0 | 15,000 | 0 |
Free Cash Flow | -59,859 | -60,410 | -94,574 | -58,592 |
Cash | 20,158 | 35,140 | 47,730 | 376,976 |
Basic Shares | 21,281 | 8,145 | 7,839 | 8,287 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.53 |
2025-03-31 | -$0.53 |
2024-12-31 | -$0.46 |
2024-09-30 | -$0.38 |
